Group One Trading
OMED

Group One Trading’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Group One Trading’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,500
Closed -$75K – 5662
2017
Q3 		$75K Buy
+16,500
New +$66.8K ﹤0.01% 3413
2017
Q2 		– Sell
-29,200
Closed -$269K – 5509
2017
Q1 		$269K Buy
29,200
+21,700
+289% +$191K ﹤0.01% 2313
2016
Q4 		$58K Buy
7,500
+6,300
+525% +$57.9K ﹤0.01% 3185
2016
Q3 		$14K Sell
1,200
-13,100
-92% -$152K ﹤0.01% 3948
2016
Q2 		$176K Buy
+14,300
New +$174K ﹤0.01% 2492
2016
Q1 		– Sell
-400
Closed -$9K – 5539
2015
Q4 		$9K Sell
400
-4,900
-92% -$100K ﹤0.01% 4242
2015
Q3 		$88K Sell
5,300
-8,000
-60% -$160K ﹤0.01% 3134
2015
Q2 		$299K Sell
13,300
-4,700
-26% -$116K ﹤0.01% 2228
2015
Q1 		$464K Buy
18,000
+9,500
+112% +$241K 0.01% 1660
2014
Q4 		$185K Buy
8,500
+3,500
+70% +$71.7K ﹤0.01% 2367
2014
Q3 		$95K Buy
+5,000
New +$100K ﹤0.01% 3051

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Group One Trading's OMED Position: Q3 2018 in Review

Group One Trading sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2018, closing a stake of 8,500 shares — an estimated $20K sold.

Group One Trading first reported a position in OMED in Q3 2015 and held it in 6 quarters. The position peaked at $452K in Q3 2015. 54 funds tracked by Wall St. Rank hold OMED as of Q3 2018.

  • Group One Trading reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Group One Trading sold 8,500 OncoMed Pharmaceuticals, Inc. shares in Q3 2018, an estimated $20K.
  • Group One Trading first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
  • Group One Trading's OncoMed Pharmaceuticals, Inc. position peaked at $452K in Q3 2015.
  • 54 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2018.

Based on Group One Trading's 13F filing for Q3 2018, filed 8 Nov 2018.